JAGX Earnings

Quarterly EPS
$-760.45
Q3 2024
$0.00
Q4 2024
$-584.45
Q1 2025
$-358.94
Q2 2025
$-181.65
Q3 2025
$-104.52
Q4 2025
$-13.60
Q1 2026
$-15.70
Q2 2026
Latest Revenue1.2M
Latest Net Income-12802000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$15.701.2M-12802000-58.9%+95.6%
Q1 2026-$13.6020.3M8.7M+815.6%+97.7%
Q4 2025-$104.523.2M-23193000-7.8%
Q3 2025-$181.653.1M-9648000-0.8%+76.1%
Q2 2025-$358.943.0M-10560000+9.5%-366.5%
Q1 2025-$584.452.2M-10596000-5.8%+76.8%
Q4 20243.5M-10234000+52.6%
Q3 2024-$760.453.1M-10021000+10.5%+95.3%
Q2 2024-$76.942.7M-9628000
Q1 2024-$2,520.002.4M-9368000
Q4 2023-$4,598.372.3M-9309000
Q3 2023-$16,270.662.8M-7904000
Jaguar Health (JAGX) — Earnings